22,836 Shares in CVS Health Corporation $CVS Purchased by HBK Sorce Advisory LLC

HBK Sorce Advisory LLC bought a new stake in shares of CVS Health Corporation (NYSE:CVS) in the second quarter, Holdings Channel reports. The fund bought 22,836 shares of the pharmacy operator’s stock, valued at approximately $2,264,000.

Several other institutional investors have also recently made changes to their positions in CVS. Beaird Harris Wealth Management LLC increased its position in shares of CVS Health by 201.0% in the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 195 shares during the last quarter. J.Safra Asset Management Corp purchased a new position in CVS Health in the 2nd quarter worth $30,000. Swiss RE Ltd. bought a new stake in shares of CVS Health in the 4th quarter valued at about $26,000. Sankala Group LLC purchased a new stake in shares of CVS Health during the fourth quarter valued at approximately $28,000. Finally, Caitong International Asset Management Co. Ltd boosted its position in CVS Health by 407.2% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 281 shares during the period. Institutional investors own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

CVS has been the subject of several recent analyst reports. DA Davidson upped their price objective on shares of CVS Health from $80.00 to $100.00 and gave the company a “buy” rating in a research note on Thursday, May 7th. JPMorgan Chase & Co. boosted their price target on CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. Cantor Fitzgerald upped their price target on CVS Health from $100.00 to $110.00 and gave the company an “overweight” rating in a research report on Tuesday, July 7th. Piper Sandler reiterated an “overweight” rating and issued a $113.00 price objective on shares of CVS Health in a report on Monday, June 1st. Finally, Wells Fargo & Company lifted their price objective on CVS Health from $103.00 to $123.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. Twenty-two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $106.75.

CVS Health Trading Down 0.1%

Shares of CVS opened at $97.09 on Monday. CVS Health Corporation has a 1-year low of $67.42 and a 1-year high of $110.68. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74. The firm’s 50-day moving average price is $102.52 and its 200-day moving average price is $88.26. The firm has a market capitalization of $124.18 billion, a price-to-earnings ratio of 25.69, a PEG ratio of 0.93 and a beta of 0.61.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business had revenue of $106.10 billion during the quarter, compared to analyst estimates of $100.03 billion. During the same period last year, the business posted $1.81 earnings per share. CVS Health’s quarterly revenue was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Sell-side analysts anticipate that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were given a dividend of $0.665 per share. The ex-dividend date was Thursday, July 23rd. This represents a $2.66 annualized dividend and a dividend yield of 2.7%. CVS Health’s payout ratio is currently 70.37%.

Insiders Place Their Bets

In related news, Director Larry Robbins sold 370,462 shares of the company’s stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $93.45, for a total value of $34,619,673.90. Following the sale, the director directly owned 4,824,799 shares of the company’s stock, valued at $450,877,466.55. This represents a 7.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders sold 3,372,000 shares of company stock valued at $317,473,598 over the last 90 days. 0.85% of the stock is owned by corporate insiders.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.